Literature DB >> 17915218

VEGF modulation of retinal pigment epithelium resistance.

Zsolt Ablonczy1, Craig E Crosson.   

Abstract

Fluid accumulation into the subretinal space and the development of macular edema is a common condition in age-related macular degeneration, diabetic retinopathy, and following ocular surgery, or injury. Vascular endothelial growth factor (VEGF) and other cytokines have been implicated in the disruption of retinal pigment epithelium (RPE) barrier function and a reduction in the regulated removal of subretinal fluid; however, the cellular and molecular events linking these agents to the disruption of barrier function have not been established. In the current study, cultures of ARPE-19 and primary porcine retinal pigment epithelium (RPE) cells were utilized to investigate the effects of the VEGF-induced modifications to the barrier properties of the RPE. The barrier function was determined by transepithelial resistance (TER) measurements and morphology of the RPE monolayers. In both ARPE-19 and primary porcine RPE cells the administration of VEGF produced a significant drop in TER, and this response was only observed following apical administration. Maximum reduction in TER was reached 5h post VEGF administration. These responses were concentration-dependent with an EC(50) of 502pg/mL in ARPE-19 cells and 251pg/mL in primary porcine cells. In both ARPE-19 and primary RPE cells, the response to VEGF was blocked by pretreatment with the relatively selective VEGF-R2 antagonists, SU5416 or ZM323881, or the protein tyrosine kinase inhibitor, genistein. Administration of the relatively selective VEGF-R2 agonist, VEGF-E, also reduced TER in a concentration-dependent manner (EC(50) of 474pg/mL), while VEGF-R1 agonist, placental growth factor (PlGF), did not significantly alter the TER. Immunolocalization studies demonstrated that confluent monolayers exhibited continuous cell-to-cell ZO-1 protein contacts and apical localization of the VEGF-R2 receptors. These data provide evidence that the VEGF-induced breakdown of RPE barrier function is mediated by the activation of apically-oriented VEGF-R2 receptors. Thus, VEGF-mediated increases in RPE permeability are initiated by a rise in intraocular levels of VEGF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17915218      PMCID: PMC2199266          DOI: 10.1016/j.exer.2007.08.010

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  36 in total

Review 1.  The tight junction: a multifunctional complex.

Authors:  Eveline E Schneeberger; Robert D Lynch
Journal:  Am J Physiol Cell Physiol       Date:  2004-06       Impact factor: 4.249

2.  Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.

Authors:  Kyoko Ohno-Matsui; Takeshi Yoshida; Tomoko Uetama; Manabu Mochizuki; Ikuo Morita
Journal:  Biochem Biophys Res Commun       Date:  2003-04-11       Impact factor: 3.575

3.  Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.

Authors:  H Gille; J Kowalski; B Li; J LeCouter; B Moffat; T F Zioncheck; N Pelletier; N Ferrara
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

4.  Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy.

Authors:  N Miyamoto; Y de Kozak; J C Jeanny; A Glotin; F Mascarelli; P Massin; D BenEzra; F Behar-Cohen
Journal:  Diabetologia       Date:  2006-12-23       Impact factor: 10.122

Review 5.  Macular edema.

Authors:  Paris G Tranos; Sanjeewa S Wickremasinghe; Nikos T Stangos; Fotis Topouzis; Ioannis Tsinopoulos; Carlos E Pavesio
Journal:  Surv Ophthalmol       Date:  2004 Sep-Oct       Impact factor: 6.048

6.  Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism.

Authors:  M Elizabeth Hartnett; Alexandra Lappas; Diane Darland; Janet R McColm; Stephanie Lovejoy; Patricia A D'Amore
Journal:  Exp Eye Res       Date:  2003-11       Impact factor: 3.467

7.  Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor.

Authors:  Manlin Jin; Ernesto Barron; Shikun He; Stephen J Ryan; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

8.  IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407.

Authors:  Mark G Slomiany; Steven A Rosenzweig
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

9.  Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats.

Authors:  Alistair J Barber; David A Antonetti
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-12       Impact factor: 4.799

10.  Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.

Authors:  Monica Autiero; Johannes Waltenberger; Didier Communi; Andrea Kranz; Lieve Moons; Diether Lambrechts; Jens Kroll; Stephane Plaisance; Maria De Mol; Françoise Bono; Stefanie Kliche; Guido Fellbrich; Kurt Ballmer-Hofer; Domenico Maglione; Ulrike Mayr-Beyrle; Mieke Dewerchin; Saskia Dombrowski; Danica Stanimirovic; Paul Van Hummelen; Christoph Dehio; Daniel J Hicklin; Graziella Persico; Jean-Marc Herbert; David Communi; Masabumi Shibuya; Désiré Collen; Edward M Conway; Peter Carmeliet
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

View more
  50 in total

1.  [Anti-VEGF therapy of exudative AMD: Prognostic factors for therapy success].

Authors:  B Heimes; A Lommatzsch; M Zeimer; M Gutfleisch; G Spital; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2011-02       Impact factor: 1.059

2.  Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement.

Authors:  Mausumi Bandyopadhyay; Bärbel Rohrer
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

Review 3.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

4.  Adult human dental pulp stem cells promote blood-brain barrier permeability through vascular endothelial growth factor-a expression.

Authors:  Joshua N Winderlich; Karlea L Kremer; Simon A Koblar
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

5.  Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayers.

Authors:  Kannan Kunchithapautham; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

6.  Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo.

Authors:  Mohammad Dahrouj; Oday Alsarraf; Jake C McMillin; Yueying Liu; Craig E Crosson; Zsolt Ablonczy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-09       Impact factor: 4.799

7.  Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner.

Authors:  Kusumam Joseph; Liudmila Kulik; Beth Coughlin; Kannan Kunchithapautham; Mausumi Bandyopadhyay; Steffen Thiel; Nicole M Thielens; V Michael Holers; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

8.  High glucose promotes the migration of retinal pigment epithelial cells through increased oxidative stress and PEDF expression.

Authors:  Mitra Farnoodian; Caroline Halbach; Cassidy Slinger; Bikash R Pattnaik; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2016-07-20       Impact factor: 4.249

9.  Pre-B cell colony enhancing factor (PBEF/NAMPT/Visfatin) and vascular endothelial growth factor (VEGF) cooperate to increase the permeability of the human placental amnion.

Authors:  J M Astern; A C Collier; C E Kendal-Wright
Journal:  Placenta       Date:  2012-11-12       Impact factor: 3.481

10.  The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration.

Authors:  Anna Tsapara; Phillip Luthert; John Greenwood; Caroline S Hill; Karl Matter; Maria S Balda
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.